Ideaya Biosciences Patents – Insights & Stats (Updated 2024)

Ideaya Biosciences has a total of 245 patents globally, out of which 26 have been granted. Of these 245 patents, more than 79% patents are active. The United States of America is where Ideaya Biosciences has filed the maximum number of patents, followed by Europe (EPO) and Australia. Parallelly, the United States of America seems to be the main focused R&D centre and also is the origin country of Ideaya Biosciences.

Ideaya Biosciences was founded in 2015. The company is a precision medicine company focused on oncology, developing targeted therapies for patients identified through molecular diagnostics. Its expertise includes targeting oncogenic pathways and synthetic lethality. The lead product, IDE196, is a PKC inhibitor for cancers with GNAQ or GNA11 gene mutations.

Do read about some of the most popular patents of Ideaya Biosciences which have been covered by us in this article and also you can find Ideaya Biosciences patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Ideaya Biosciences patent portfolio.

How many patents does Ideaya Biosciences have?

Ideaya Biosciences has a total of 245 patents globally. These patents belong to 59 unique patent families. Out of 245 patents, 194 patents are active.

How Many Patents did Ideaya Biosciences File Every Year?

Ideaya Biosciences Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantIdeaya Biosciences Applications FiledIdeaya Biosciences Patents Granted
2024238
20233611
2022532
2021413
2020482
201940
20184

How many Ideaya Biosciences patents are Alive/Dead?

Worldwide Patents

Ideaya Biosciences Patent Portfolio

How Many Patents did Ideaya Biosciences File in Different Countries?

Ideaya Biosciences Worldwide Patent Filing

Countries in which Ideaya Biosciences Filed Patents

CountryPatents
United States of America32
Europe (EPO)20
Australia13
Japan13
Canada12
Taiwan12
Brazil9
Hong Kong (S.A.R.)8
Singapore8
Israel7
Mexico7
New Zealand7
Korea (South)5
South Africa5
Chile4
India4
Pakistan3
Argentina3
Russia3
Colombia3
Philippines2
Spain2
Indonesia2
Germany2
Finland1
Denmark1
Austria1
Italy1
Viet Nam1
Norway1

Where are Research Centers of Ideaya Biosciences Patents Located?

R&D Centres of Ideaya Biosciences

10 Best Ideaya Biosciences Patents

WO2020123395A1 is the most popular patent in the Ideaya Biosciences portfolio. It has received 41 citations so far from companies like Jiangsu Simcere Pharmaceutical, Nanjing Zhengda Tianqing Pharmaceutical, Xenon Pharmaceuticals.

Below is the list of 10 most cited patents of Ideaya Biosciences:

Publication NumberCitation Count
WO2020123395A141
WO2021055744A131
WO2020243459A122
WO2022256806A119
WO2022118210A114
WO2019018562A114
WO2022259204A112
WO2022026548A111
WO2020160213A110
WO2020160134A110

What are Ideaya Biosciences key innovation segments?

What Technologies are Covered by Ideaya Biosciences?

The chart below distributes patents filed by Ideaya Biosciences in different countries on the basis of the technology protected in patents. It also represents the markets where Ideaya Biosciences thinks it’s important to protect particular technology inventions.

R&D Focus: How has Ideaya Biosciences search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Ideaya Biosciences?

Related Articles

Synaffix Patents – Insights & Stats (Updated 2024)

Synaffix has a total of 293 patents globally, out of which 130 have been granted. Of these 293 patents, more than 77% patents are active. United States of America is where Synaffix has filed the maximum number of patents, followed by Europe (EPO) and China. Parallelly, Europe (EPO) seems to

Read More »

Exasun Patents – Insights & Stats (Updated 2024)

Exasun has a total of 15 patents globally, out of which 2 have been granted. Of these 15 patents, more than 80% patents are active. United States of America is where Exasun has filed the maximum number of patents, followed by Europe (EPO) and Netherlands. Parallelly, Netherlands seems to be

Read More »

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.